BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4354051)

  • 1. Effect of pH on electron-paramagnetic-resonance spectra of ceruloplasmin.
    Gunnarsson PO; Nylén U; Pettersson G
    Eur J Biochem; 1973 Aug; 37(1):47-50. PubMed ID: 4354051
    [No Abstract]   [Full Text] [Related]  

  • 2. Anion-binding and the state of copper in caeruloplasmin.
    Byers W; Curzon G; Garbett K; Speyer BE; Young SN; Williams RJ
    Biochim Biophys Acta; 1973 May; 310(1):38-50. PubMed ID: 4351064
    [No Abstract]   [Full Text] [Related]  

  • 3. Presence of reduced type 1 copper in ceruloplasmin as revealed by reaction with hydrogen peroxide.
    Calabrese L; Leuzzi U
    Biochem Int; 1984 Jan; 8(1):35-9. PubMed ID: 6089818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of the interaction between ceruloplasmin and reducing substrates.
    Gunnarsson PO; Nylén U; Pettersson G
    Eur J Biochem; 1973 Aug; 37(1):41-6. PubMed ID: 4729428
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of the redox state of the copper sites of human ceruloplasmin by chloride.
    Musci G; Bonaccorsi di Patti MC; Calabrese L
    J Protein Chem; 1995 Oct; 14(7):611-9. PubMed ID: 8561857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ratio of type-I and -2 Cu(II) in human ceruloplasmin.
    Veldsema A; van Gelder BF
    Biochim Biophys Acta; 1973 Feb; 293(2):322-33. PubMed ID: 4351260
    [No Abstract]   [Full Text] [Related]  

  • 7. Spectroscopic and magnetic studies of human ceruloplasmin: identification of a redox-inactive reduced Type 1 copper site.
    Machonkin TE; Zhang HH; Hedman B; Hodgson KO; Solomon EI
    Biochemistry; 1998 Jun; 37(26):9570-8. PubMed ID: 9649340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of a specific copper(II) in human ceruloplasmin as a binding site for inhibitory anions.
    Andréasson LE; Vänngård T
    Biochim Biophys Acta; 1970 Feb; 200(2):247-57. PubMed ID: 4313536
    [No Abstract]   [Full Text] [Related]  

  • 9. Anaerobic oxidation-reduction titrations of human ceruloplasmin. Evidence for diamagnetic electron-acceptors in the protein.
    Carrico RJ; Malmströn BG; Vänngård T
    Eur J Biochem; 1971 Jun; 20(4):518-24. PubMed ID: 4325877
    [No Abstract]   [Full Text] [Related]  

  • 10. The stoichiometry of the paramagnetic copper and the oxidation-reduction potentials of type I copper in human ceruloplasmin.
    Deinum J; Vänngård T
    Biochim Biophys Acta; 1973 Jun; 310(2):321-30. PubMed ID: 4352493
    [No Abstract]   [Full Text] [Related]  

  • 11. [Quarternary structure of human ceruloplasmin].
    Vasilets IM; Konnova LA; Kushner VP; Bozhkov VM; Zdrodovskaia EP; Mukha GV
    Biokhimiia; 1968; 33(6):1285-95. PubMed ID: 5751505
    [No Abstract]   [Full Text] [Related]  

  • 12. The reaction of cysteine with ceruloplasmin copper.
    Chidambaram MV; Zgirski A; Frieden E
    J Inorg Biochem; 1984 Jul; 21(3):227-39. PubMed ID: 6088686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The state of copper in stellacyanin and laccase from the lacquer tree Rhus vernicifera.
    Malmström BG; Reinhammar B; Vänngård T
    Biochim Biophys Acta; 1970 Apr; 205(1):48-57. PubMed ID: 4314765
    [No Abstract]   [Full Text] [Related]  

  • 14. An e.p.r. study of the non-equivalence of the copper sites of caeruloplasmin.
    Calabrese L; Carbonaro M
    Biochem J; 1986 Aug; 238(1):291-5. PubMed ID: 3026345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of diethylpyrocarbonate on some physical and chemical properties of ceruloplasmin.
    Nylén U; Petersson G
    Eur J Biochem; 1972 Jun; 27(3):578-84. PubMed ID: 4340516
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of fluoride on the spectral and catalytic properties of the three copper-containing oxidases.
    Brändén R; Malmström BG; Vänngård T
    Eur J Biochem; 1973 Jul; 36(1):195-200. PubMed ID: 4354619
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigation of the anomalous spectroscopic features of the copper sites in chicken ceruloplasmin: comparison to human ceruloplasmin.
    Machonkin TE; Musci G; Zhang HH; Bonaccorsi di Patti MC; Calabrese L; Hedman B; Hodgson KO; Solomon EI
    Biochemistry; 1999 Aug; 38(34):11093-102. PubMed ID: 10460165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the catalytic oxidation of cysteine and o-dianisidine by cupric ion and ceruloplasmin.
    Feldman SL; Hunter JS; Zgirski A; Chidambaram MV; Frieden E
    J Inorg Biochem; 1982 Aug; 17(1):51-60. PubMed ID: 7119774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EPR study of nitric oxide-treated reduced ceruloplasmin.
    van Leeuwen FX; Wever R; van Gelder BF
    Biochim Biophys Acta; 1973 Jul; 315(1):200-3. PubMed ID: 4355267
    [No Abstract]   [Full Text] [Related]  

  • 20. Ceruloplasmin in human plasma and its relationships with the copper-albumin complex.
    Musci G; Bonaccorsi di Patti MC; Carlini P; Calabrese L
    Eur J Biochem; 1992 Dec; 210(2):635-40. PubMed ID: 1333956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.